Literature DB >> 16651366

Non-coding RNA.

John S Mattick1, Igor V Makunin.   

Abstract

The term non-coding RNA (ncRNA) is commonly employed for RNA that does not encode a protein, but this does not mean that such RNAs do not contain information nor have function. Although it has been generally assumed that most genetic information is transacted by proteins, recent evidence suggests that the majority of the genomes of mammals and other complex organisms is in fact transcribed into ncRNAs, many of which are alternatively spliced and/or processed into smaller products. These ncRNAs include microRNAs and snoRNAs (many if not most of which remain to be identified), as well as likely other classes of yet-to-be-discovered small regulatory RNAs, and tens of thousands of longer transcripts (including complex patterns of interlacing and overlapping sense and antisense transcripts), most of whose functions are unknown. These RNAs (including those derived from introns) appear to comprise a hidden layer of internal signals that control various levels of gene expression in physiology and development, including chromatin architecture/epigenetic memory, transcription, RNA splicing, editing, translation and turnover. RNA regulatory networks may determine most of our complex characteristics, play a significant role in disease and constitute an unexplored world of genetic variation both within and between species.

Mesh:

Substances:

Year:  2006        PMID: 16651366     DOI: 10.1093/hmg/ddl046

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  906 in total

Review 1.  Are snoRNAs and snoRNA host genes new players in cancer?

Authors:  Gwyn T Williams; Farzin Farzaneh
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

2.  Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells.

Authors:  Jung Ki Yoo; Jumi Kim; Seong-Jun Choi; Hye Min Noh; Young Do Kwon; Hanna Yoo; Hyo Seon Yi; Hyung Min Chung; Jin Kyeoung Kim
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

Review 3.  Epigenetic control on cell fate choice in neural stem cells.

Authors:  Xiao-Ling Hu; Yuping Wang; Qin Shen
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

4.  RNA and its ionic cloud: solution scattering experiments and atomically detailed simulations.

Authors:  Serdal Kirmizialtin; Suzette A Pabit; Steve P Meisburger; Lois Pollack; Ron Elber
Journal:  Biophys J       Date:  2012-02-21       Impact factor: 4.033

5.  Thermodynamic and kinetic analysis of an RNA kissing interaction and its resolution into an extended duplex.

Authors:  Nilshad Salim; Rajan Lamichhane; Rui Zhao; Tuhina Banerjee; Jane Philip; David Rueda; Andrew L Feig
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

Review 6.  Cancer induction and suppression with transcriptional control and epigenome editing technologies.

Authors:  Shota Nakade; Takashi Yamamoto; Tetsushi Sakuma
Journal:  J Hum Genet       Date:  2017-11-14       Impact factor: 3.172

7.  Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.

Authors:  Xudong Chen; Guoqiang Zhao; Fuqing Wang; Fenglan Gao; Hailan Luo; Yuanyuan Wang; Yuwen Du; Xiaonan Chen; Changgui Xue; Ziming Dong; Guohua Song
Journal:  Tumour Biol       Date:  2014-08-06

8.  LncRNA SOX2OT affects cervical cancer cell growth, migration and invasion by regulating SOX2.

Authors:  Xiaohan Chang; Huijie Zhang; Qing Yang; Li Pang
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

Review 9.  The rise of regulatory RNA.

Authors:  Kevin V Morris; John S Mattick
Journal:  Nat Rev Genet       Date:  2014-04-29       Impact factor: 53.242

Review 10.  The pancreatic β-cell transcriptome and integrated-omics.

Authors:  David M Blodgett; Anthony J Cura; David M Harlan
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.